Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,246 public trials 1,181 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Active, Not Recruiting

Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC

NCT05765825

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • Chongqing University cancer hospital Chongqing, Chongqing Municipality, China
  • Cancer Hospital of Shantou University Medical College Shantou, Guangdong, China
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • LiaoNing Cancer Hospital & Institute Shenyang, Liaoning, China
View Trial Details
Active, Not Recruiting

A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

NCT05879978

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Hôpital Louis Pradel Bron, France
  • CTR François Baclesse Caen, France
View Trial Details
Active, Not Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

NCT04913285

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • The Angeles Clinic Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • University of California San Diego, Moores Cancer Center San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 50 locations
View Trial Details
Active, Not Recruiting

Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy

NCT06736418

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Large Cell Neuroendocrine Carcinoma of the Lung, +9 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of California, Los Angeles Santa Monica, California, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
View Trial Details
Active, Not Recruiting

POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC

NCT05782361

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • DDU, Royal Marsden Hospital NHS Foundation Trust Sutton, Surrey, United Kingdom
  • University College London Hospitals NHS Foundation Trust London, United Kingdom
  • Lung Unit, Royal Marsden Hospital NHS Foundation Trust London, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
View Trial Details
Active, Not Recruiting

A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

NCT04280081

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The First Affiated Hospital Of Guangzhou Medical University Guangzhou, Guangdong, China
  • Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View all 13 locations
View Trial Details
Active, Not Recruiting

Whole Genomic Landscape of Advanced EGFR-mutant NSCLC

NCT03969823

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Seoul National University Bundang Hospital Seongnam, South Korea
  • Borame Medical Center Seoul, South Korea
  • Seoul National University Hospital Seoul, South Korea
View Trial Details
Active, Not Recruiting

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

NCT03778229

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +10 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Sacramento, California, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 90 locations
View Trial Details

Related conditions